University of Newcastle, Newcastle upon Tyne , United Kingdom

University of Alabama at Birmingham, Birmingham , United States

Matthew Alexander is Associate Professor and serves as the UAB Center for Exercise Medicine (UCEM) Education Chair. His laboratory focuses on identifying novel epigenetic and genetic regulators of human neuromuscular diseases and generating novel zebrafish models of disease for drug screening purposes.

Mayo Clinic, Rochester , United States

Dr. Liewluck is a Professor of Neurology at the Mayo Clinic College of Medicine in Rochester, Minnesota, USA. He obtained his medical degree from the Faculty of Medicine, Siriraj Hospital, Mahidol University in Thailand, and pursued a neuromuscular research fellowship at the National Center of Neurology and Psychiatry of Japan under the directorship of Professor Ichizo Nishino. He furthered his expertise with a neurology residency at the University of Miami Miller School of Medicine, followed by dual fellowships in Clinical Neurophysiology (EMG) and Muscle Diseases at the Mayo Clinic in Rochester under the directorship of the late Professor Andrew G. Engel. Dr. Liewluck holds board certifications in Neurology, Neuromuscular Medicine, and Clinical Neuromuscular Pathology. His clinical practice and research focus on a comprehensive understanding of muscle diseases, particularly acquired myopathies. He has authored over 130 peer-reviewed articles and nine book chapters and co-edited one book. Dr. Liewluck is actively involved in professional organizations such as the WMS, AAN, ANA, AANEM, IMACS, and IMyoS. He served as chair of the ANA Neuromuscular Disease Special Interest Group in 2023, vice chair of the AAN Neuromuscular Section from 2023 to 2025, and vice chair of the IMACS Scientific Committee from 2023 to 2025. Dr. Liewluck currently chairs the Abstract Review Committee of the AANEM and is an associate board member of IMyoS.

Children's Hospital of Philadelphia, Philadelphia , United States

I am a pediatric neuromuscular physician at the Children's Hospital of Philadelphia. In 2023, I became the inaugural Medical Director of Clinical In Vivo Gene Therapy, focusing on bringing new therapies to patients and building a safety and education infrastructure around these products.

NIH/NINDS, North Bethesda , United States

Harry Perkins Institute of Medical Research and UWA, Perth , Australia

I would welcome more active involvement with the WMS. The society needs greater representation by women at the Executive/Leadership level and could do more to grow and develop emerging/junior researchers. There is a lot of financial support and the training course is wonderful but more could be done around mentoring, career development.